home
Molnupiravir News
Molnupiravir NEWS
healthcare | Mar 28, 2022 1:07 PM ISTDon’t see opportunity for Paxlovid in EMs; no visibility on market size for Molnupiravir: Laurus Labs
healthcare | Mar 22, 2022 3:25 PM ISTPfizer to share technology for COVID-19 antiviral drug, Paxlovid
market | Feb 11, 2022 12:41 PM ISTDivi's Labs Q3 Earnings: Profit jumps 92% to Rs 902 crore, beats Street estimates
healthcare | Jan 30, 2022 3:52 PM IST2 years on, vaccines, following protocols remain most effective weapons against COVID-19
business | Jan 7, 2022 9:03 AM ISTLupin launches Molnupiravir under brand 'Molnulup' for COVID treatment
- healthcare | Jan 7, 2022 7:59 AM IST
How did Molnupiravir become a part of COVID treatment globally? Details here
healthcare | Jan 5, 2022 11:20 PM ISTCOVID antiviral drug Molnupiravir has major safety concerns: ICMR chief
healthcare | Jan 4, 2022 6:48 PM ISTDr Reddy's to launch Molflu at Rs 35 per capsule for COVID treatment
healthcare | Jan 4, 2022 6:32 PM ISTAs COVID-19 antiviral Molnupiravir launches in India; here's all you need to know about the pill
market | Dec 29, 2021 2:50 PM ISTSun Pharma, Dr Reddy's, Divi's, other pharma stocks in high demand on Molnupiravir nod
healthcare | Dec 29, 2021 10:41 AM ISTMolnupiravir unlikely to make big impact on Indian companies: Research Delta Advisors
- healthcare | Dec 28, 2021 8:24 PM IST
Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly
healthcare | Dec 28, 2021 5:04 PM ISTExperts' take on 'precautionary dose' and vaccine for kids
- healthcare | Dec 28, 2021 9:26 AM IST
SEC grants EUA for anti-COVID pill Molnupiravir after application from 6 pharma firms
healthcare | Dec 2, 2021 2:59 PM ISTUK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'